Five things to know:
- In the first study, researchers analyzed 1.2 million EHR notes and more than 130,000 patients within the Mayo system. They compared post-vaccination follow-ups of 51,795 patients who received the Pfizer vaccine, 16,471 patients who received the Moderna vaccine and 68,266 who did not get vaccinated.
- The study found vaccinated patients were likely to experience muscle and joint soreness, myalgia, headache and fatigue, but were not more likely than unvaccinated patients to seek out emergency care.
- Severe events include anaphylaxis, facial paralysis and cerebral venous sinus thrombosis. These events were rare and occurred at similar rates in vaccinated and unvaccinated individuals, the study said.
- In the second study, the researchers analyzed the effectiveness of the Moderna and Pfizer vaccines. They analyzed rates of positive COVID-19 test results, hospitalization and ICU admission.
- The study found Pfizer is 86 percent effective against COVID-19 and Moderna is 93 percent effective. Both vaccines were 100 percent effective in preventing COVID-19-related ICU admissions.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
